Abstract:Intrinsically disordered peptides, such as amyloid β42 (Aβ42), lack a well-defined structure in solution. Aβ42 can undergo abnormal aggregation and amyloidogenesis in the brain, forming fibrillar plaques, a hallmark of Alzheimer's disease. The insoluble fibrillar forms of Aβ42 exhibit well-defined, cross β-sheet structures at the molecular level and are less toxic than the soluble, intermediate disordered oligomeric forms. However, the mechanism of initial interaction of monomers and subsequent oligomerization is not well understood. The structural disorder of Aβ42 adds to the challenges of determining the structural properties of its monomers, making it difficult to understand the underlying molecular mechanism of pathogenic aggregation. Certain regions of Aβ42 are known to exhibit helical propensity in different physiological conditions. NMR spectroscopy has shown that the Aβ42 monomer at lower pH can adopt an α-helical conformation and as the pH is increased, the peptide switches to β-sheet conformation and aggregation occurs. CD spectroscopy studies of aggregation have shown the presence of an initial spike in the amount of α-helical content at the start of aggregation. Such an increase in α-helical content suggests a mechanism wherein the peptide can expose critical non-polar residues for interaction, leading to hydrophobic aggregation with other interacting peptides. We have used molecular dynamics simulations to characterize in detail the conformational landscape of monomeric Aβ42 in solution to identify molecular properties that may mediate the early stages of oligomerization. We hypothesized that conformations with α-helical structure have a higher probability of initiating aggregation because they increase the hydrophobicity of the peptide. Although random coil conformations were found to be the most dominant, as expected, α-helical conformations are thermodynamically accessible, more so than β-sheet conformations. Importantly, for the first time α-helical conformations are observed to increase the exposure of aromatic and hydrophobic residues to the aqueous solvent, favoring their hydrophobically driven interaction with other monomers to initiate aggregation. These findings constitute a first step toward characterizing the mechanism of formation of disordered, low-order oligomers of Aβ42.

Spontaneous formation of -sheet nano-barrels during the early aggregation of Alzheimer's amyloid beta

Spontaneous formation of β-sheet nano-barrels during the early aggregation of Alzheimer’s amyloid beta

Energy Landscapes of the Monomer and Dimer of the Alzheimer’s Peptide Aβ(1–28)

Self-Assembly Pathways of Β-Sheet-rich Amyloid-β(1-40) Dimers: Markov State Model Analysis on Millisecond Hybrid-Resolution Simulations.

Self-Assembly of Full-Size Amyloid Beta 40 Proteins in Dimers

Induced Beta-Barrel Formation of the Alzheimer'S A Beta 25-35 Oligomers on Carbon Nanotube Surfaces: Implication for Amyloid Fibril Inhibition

Anatomy and Formation Mechanisms of Early Amyloid-Β Oligomers with Lateral Branching: Graph Network Analysis on Large-Scale Simulations.

Self-Assembling ABETA(30-36) Peptides: A Combined All-Atom and Coarse-Grained Simulation Study

Molecular Dynamics Simulations of Low-Ordered Alzheimer Β-Amyloid Oligomers from Dimer to Hexamer on Self-Assembled Monolayers

Co-aggregation of α-synuclein with Amyloid-β Stabilizes β-sheet-rich Oligomers and Enhances the Formation of β-barrels

Pathway Complexity of Alzheimer's β-Amyloid Aβ16-22 Peptide Assembly

Metastable alpha-rich and beta-rich conformations of small Aβ42 peptide oligomers

Polymorphic C-terminal beta-sheet interactions determine the formation of fibril or amyloid beta-derived diffusible ligand-like globulomer for the Alzheimer Abeta42 dodecamer.

The role of α-sheet structure in amyloidogenesis: characterization and implications

Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers.

Molecular Dynamics Simulations of Alzheimer Abeta40 Elongation and Lateral Association.

Pathway Complexity Of Alzheimer'S Beta-Amyloid A Beta(16-22) Peptide Assembly

Characterization of the Conformations of Amyloid Beta 42 in Solution That May Mediate Its Initial Hydrophobic Aggregation

Compilation and Analysis of Enzymes, Engineered Antibodies, and Nanoparticles Designed to Interfere with Amyloid-Beta Aggregation

Molecular Mechanism of Misfolding and Aggregation of Aβ(13-23).

Structural Insights into the Co-Aggregation of Aβ and Tau Amyloid Core Peptides: Revealing Potential Pathological Heterooligomers by Simulations.